JP2008063280A - 皮膚用化粧料 - Google Patents
皮膚用化粧料 Download PDFInfo
- Publication number
- JP2008063280A JP2008063280A JP2006243356A JP2006243356A JP2008063280A JP 2008063280 A JP2008063280 A JP 2008063280A JP 2006243356 A JP2006243356 A JP 2006243356A JP 2006243356 A JP2006243356 A JP 2006243356A JP 2008063280 A JP2008063280 A JP 2008063280A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- cosmetic
- polyol
- lecithin
- ascorbic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 40
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 43
- 229920005862 polyol Polymers 0.000 claims abstract description 27
- 150000003077 polyols Chemical class 0.000 claims abstract description 27
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 22
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 21
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 21
- 102000011782 Keratins Human genes 0.000 claims abstract description 15
- 108010076876 Keratins Proteins 0.000 claims abstract description 15
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 20
- 239000000787 lecithin Substances 0.000 claims description 18
- 235000010445 lecithin Nutrition 0.000 claims description 18
- 229940067606 lecithin Drugs 0.000 claims description 17
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 5
- 238000002156 mixing Methods 0.000 abstract description 3
- 230000007794 irritation Effects 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 34
- 210000003491 skin Anatomy 0.000 description 26
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 235000011187 glycerol Nutrition 0.000 description 17
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- 230000003020 moisturizing effect Effects 0.000 description 9
- 229940058015 1,3-butylene glycol Drugs 0.000 description 5
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 5
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 description 5
- 239000008347 soybean phospholipid Substances 0.000 description 5
- 239000006071 cream Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229940083466 soybean lecithin Drugs 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 150000000996 L-ascorbic acids Chemical class 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229920000800 acrylic rubber Polymers 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229940099578 hydrogenated soybean lecithin Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 125000001095 phosphatidyl group Chemical group 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000011863 silicon-based powder Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Abstract
【解決手段】
ポリオールを、水を使用せず、ホスファチジルコリンを用いてゲル化してなることを特徴とする皮膚用化粧料。ホスファチジルコリンの配合量は、化粧料全量の1〜15wt%とするのが好ましい。また、アスコルビン酸を添加しておけば、より効果的である。
【選択図】なし
Description
ポリオールとして濃グリセリン、1,3−ブチレングリコール、プロピレングリコールを用い、水素添加レシチンとして2種の大豆レシチン、すなわちフォスファチジルコリン(PC)含有量25〜30wt%の大豆レシチンAと、フォスファチジルコリン含有量55〜65wt%の大豆レシチンBの2種、及び、通常化粧料に使用される他の種々の成分を配合したした化粧料を試作した。その内容は表1に示すとおりである。表1における配合量の割合は、すべてwt%で表されている。
Claims (3)
- 角質が高度に硬化した部位に使用し該硬化した角質を柔らかくするための皮膚用化粧料であって、必須成分としてポリオールとレシチンとを含み、前記ポリオールがレシチンでゲル化されていることを特徴とする皮膚用化粧料。
- 化粧量全量の0.1〜20wt%のアスコルビン酸を含有する請求項1に記載の皮膚用化粧料。
- レシチンに含まれるホスファチジルコリンの配合量が化粧料全量の1〜15wt%である請求項1又は2に記載の皮膚用化粧料。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006243356A JP5141942B2 (ja) | 2006-09-07 | 2006-09-07 | 皮膚用化粧料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006243356A JP5141942B2 (ja) | 2006-09-07 | 2006-09-07 | 皮膚用化粧料 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008063280A true JP2008063280A (ja) | 2008-03-21 |
JP5141942B2 JP5141942B2 (ja) | 2013-02-13 |
Family
ID=39286284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006243356A Expired - Fee Related JP5141942B2 (ja) | 2006-09-07 | 2006-09-07 | 皮膚用化粧料 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5141942B2 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010120885A (ja) * | 2008-11-20 | 2010-06-03 | Osaka City Univ | コラーゲン産生向上剤及び皮膚用化粧料 |
WO2013031496A1 (ja) * | 2011-09-01 | 2013-03-07 | 株式会社ダイセル | 油性ゲル状組成物を用いたヘアオイル |
WO2013081120A1 (ja) * | 2011-11-30 | 2013-06-06 | 学校法人日本大学 | レシチンオルガノゲル形成剤 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004331529A (ja) * | 2003-05-02 | 2004-11-25 | Tsugio Oda | 皮膚用化粧品 |
JP2005263793A (ja) * | 2004-02-18 | 2005-09-29 | Rohto Pharmaceut Co Ltd | 皮膚外用剤 |
-
2006
- 2006-09-07 JP JP2006243356A patent/JP5141942B2/ja not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004331529A (ja) * | 2003-05-02 | 2004-11-25 | Tsugio Oda | 皮膚用化粧品 |
JP2005263793A (ja) * | 2004-02-18 | 2005-09-29 | Rohto Pharmaceut Co Ltd | 皮膚外用剤 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010120885A (ja) * | 2008-11-20 | 2010-06-03 | Osaka City Univ | コラーゲン産生向上剤及び皮膚用化粧料 |
WO2013031496A1 (ja) * | 2011-09-01 | 2013-03-07 | 株式会社ダイセル | 油性ゲル状組成物を用いたヘアオイル |
WO2013081120A1 (ja) * | 2011-11-30 | 2013-06-06 | 学校法人日本大学 | レシチンオルガノゲル形成剤 |
JPWO2013081120A1 (ja) * | 2011-11-30 | 2015-04-27 | 学校法人日本大学 | レシチンオルガノゲル形成剤 |
Also Published As
Publication number | Publication date |
---|---|
JP5141942B2 (ja) | 2013-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW510801B (en) | Skin toning formulation | |
FR2798078A1 (fr) | Organogel, comprenant un compose hydrophile sensible a l'oxydation et ses utilisations notamment cosmetiques | |
JPWO2006118245A1 (ja) | 皮膚再生促進剤 | |
JP2013209320A (ja) | アスコルビン酸誘導体が配合されたリポソーム組成物 | |
JP5148127B2 (ja) | ナノエマルジョン、その製造方法ならびにそれを含む化粧用および皮膚用組成物 | |
KR102127674B1 (ko) | 실리콘-프리 및 피이지-프리의 워터 드롭 고형타입 유중수형 화장료 조성물 및 이의 제조방법 | |
TW200922631A (en) | Vesicle composition and external preparation for skin | |
JP5141942B2 (ja) | 皮膚用化粧料 | |
JP2007153866A (ja) | 乳化型化粧料 | |
KR101507891B1 (ko) | 액정 겔 수화기술을 이용한 피부 보습 및 유연성 개선효과를 나타내는 화장료 조성물 및 그의 제조방법 | |
CN103648470B (zh) | 水包油型皮肤外用剂 | |
JP2000327529A (ja) | クレンジング化粧料 | |
JP4806601B2 (ja) | 液体入浴剤 | |
CN1238176A (zh) | L-2-氧代噻唑烷-4-羧酸与多元醇的结合使用 | |
JP2013032302A (ja) | 皮膚外用剤およびその製造方法 | |
JP5793056B2 (ja) | 化粧料 | |
JP5865623B2 (ja) | 皮膚外用剤およびその製造方法 | |
KR20160063661A (ko) | 킬레이팅 효과가 있는 폴리머를 이용한 알진 캡슐 붕해용 화장료 조성물 | |
KR20220044256A (ko) | 고함량의 버터를 포함하는 수중유형 화장료 조성물 | |
JP2007269672A (ja) | 皮膚外用剤 | |
JP4814745B2 (ja) | 液体入浴剤 | |
JP2002145733A (ja) | 固形状油中水型乳化化粧料 | |
JPH04217612A (ja) | ゲル状毛髪化粧料 | |
JP2012219029A (ja) | メラニン色素排出用組成物 | |
JP2003146872A (ja) | 脂質分散組成物及びこれを含有する皮膚外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090218 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110217 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110412 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110606 |
|
RD05 | Notification of revocation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7425 Effective date: 20110609 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120117 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120306 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20121106 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20121107 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20211130 Year of fee payment: 9 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5141942 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees | ||
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |